- Basch EM, Cruz ME, Tapia D, Cruz A. Prevalence of epilepsy in a migrant population near Quito, Ecuador. Neuroepidemiology 1997;16:94-98.
- Basch EM, Bonfiglio MF. Pharmaceutical manufacturer sponsorship and drug information. Archives of Internal Medicine 2001;161:2625-2526.
- Basch E, Yakren S, Thaler HT, Shi W, Schrag D. Use of information resources by cancer patients and their companions. Cancer 2004;100:2476-2483.
- Basch E, Artz D, Dulko D, Scher K, Sabbatini P, Hensley M, Mitra N, Speakman J, McCabe M, Schrag D. Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol 2005;23(15):3552-3561.
- Basch EM, Servoss JC, Tedrow UB. Safety assurances for dietary supplements policy issues and new research paradigms. J Herb Pharmacother 2005;5(1):3-15.
- Ulbricht C, Basch E, Weissner W, Hackman D. Systematic review of herb and supplement interactions. Expert Opin Drug Safety 2006;5(5):719-28.
- Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, Scher HI, Schrag D. Clinician versus patient self-reporting of symptoms during cancer treatment: a paired analysis using the National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE). Lancet Oncol 2006;7(10): 903-909.
- Basch E, Artz D, Speakman J, Iasonos A, Shannon K, Lin K, Pun C, Yong H, Barz A, McCabe M, Schrag D. Design, implementation, and evaluation of a web portal for patient symptom monitoring. J Am Med Inform Assoc 2007;14(3):264-268.
- Basch E, Iasonos A, Barz A, Culkin A, Kris MG, Artz D, Fearn P, Speakman J, Farquhar R, Scher HI, McCabe M, Schrag D. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol 2007;25(34):5374-80.
- Trotti A, Colevas AD, Setser A, Basch E. Patient-Reported Outcomes and the Evolution of Adverse Event Reporting in Oncology. J Clin Oncol 2007; 25(32):5121-7.
- Basch E. Expectations for specialized knowledge in oncology. Nature Clin Pract Oncol 2007;4(5):263.
- Basch E, Somerfield M, Beer TM, Carducci MA, Higano CS, Hussian M, Scher HI. American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Non-hormonal Therapy for Men with Metastatic Hormone-refractory (Castration-resistant) Prostate Cancer. J Clin Oncol 2007: 25(33):5313-8.
- Bekelman JE, Zelefsky MJ, Jang TL, Basch EM, Schrag D. Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1456-66.
- Bekelman JE, Zelefsky MJ, Jang TL, Basch EM, Elkin E, Smith BD, Liu Y, Schrag D. Patterns of use of Intensity-Modulated and Conventional Radiotherapy Among Radiation Oncologists Who Treat Older Men With Non-Metastatic Prostate Cancer. Int J Radiat Oncol Biol Phys 2007; 69(3):S554-S555
- Scher HI, Halabi S, Tannock I, Morris M, Carducci M, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, Petrylak D, Kantoff P, Heller G, Basch E, Kelly WK, Figg W, Small EJ, Beer TM, Sternberg C, Wilding G, Martin A, Hussain M. Design and Endpoints of Phase 2 Trials for Patients with Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group (PCWG2). J Clin Oncol 2008 Mar 1; 26(7):1148-59.
- Motzer RJ, Basch E. Targeted Drugs for Metastatic Renal Cell Carcinoma: Weighing Benefits and Costs. Lancet 2007 Dec 22;370(9605):2071-3.
- Vickers A, Basch E, Kattan MW. Against Diagnosis. Ann Intern Med 2008;149 200-203.
- Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Lenderking WR, Cella D, Basch E. Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures: ISPOR ePRO Good Research Practices Task Force Report. Value in Health 2008. Published Online ahead of Print: Nov 11 2008.
- Basch E, Goldfarb S. Electronic patient-reported outcomes (ePROs) for collecting sensitive information from patients. J Support Oncol 2009 (in press).
|
